OSBORN
v.
NOVARTIS PHARMACEUTICALS CORPORATION
AI-generated. These summaries, headnotes, and key points are machine-generated and may contain errors or omissions. Always verify against the full opinion text below. Not legal advice.
This order sets forth the initial scheduling and case management procedures for the lawsuit.
Plaintiff Robin Osborn filed a lawsuit against Defendant Novartis Pharmaceuticals Corporation. The court issued an Initial Scheduling Order to manage …
The full statement of facts, procedural history, and disposition for this case are member content.
Join FLexlaw to unlock all legal intelligence© FLexlaw, Inc. — AI-generated enrichments are proprietary. All rights reserved.
Explore caselaw by topic → Browse Daubert Hearing cases and more on FLexlaw
This case is assigned to me for scheduling, case management, discovery and other nondispositive motions. The Federal Rules of Civil Procedure, as amended, as well as the Local Rules of the Court will apply to this lawsuit. The parties, appearing through counsel or pro se, will “meet and confer” no later than Wednesday, May 31, 2023, to formulate a provisional discovery plan. FED. R. CIV. P. 26(f). The time allowed for discovery is generally 120 to 150 days. The parties will cooperate in preparing a Joint Status Report and Provisional Discovery Plan (“JSR”) which follows the sample JSR available at the Court’s web site.1 The blanks for suggested/proposed dates are to be filled in by the parties. Actual dates will be promulgated by order of the court shortly after entry of the JSR. Plaintiff, or Defendant in removed cases, is responsible for filing the JSR by Wednesday, June 28, 2023.
KS KS D
UNITED STATES MAGISTRATEJUDGE
Daubert v. Merrell Dow Pharmaceuticals, 509 U.S. 579 (1993).